Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?

Sorry, there's nothing here.

Cite this paper

@article{Caine2003IsLH, title={Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?}, author={Graham J Caine and Gregory Y . H . Lip}, journal={Archives of internal medicine}, year={2003}, volume={163 10}, pages={1243-4; author reply 1244} }